Next-Generation Sequencing's Value in NSCLC

(MedPage Today) -- The use of broad-panel, next-generation sequencing (NGS) proved to be more cost-effective than single-gene testing in patients with non-squamous non-small cell lung cancer, according to a study presented during the recent American...